InvaGen Pharmaceuticals, Inc.

Insider Reports History

Location
Hauppauge, NY
Signature
INVAGEN PHARMACEUTICALS INC. /s/ Deepak Agarwal By: Deepak Agarwal Title: Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by InvaGen Pharmaceuticals, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
AVENUE THERAPEUTICS, INC. 10%+ Owner Common Stock, par value $0.0001 per share 0 11 Oct 2022 Direct
AVENUE THERAPEUTICS, INC. 10%+ Owner Common Stock, par value $0.0001 per share 0 11 Oct 2022 Indirect

Insider Reports Filed by InvaGen Pharmaceuticals, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXI AVENUE THERAPEUTICS, INC. 11 Oct 2022 1 -$2,999,882 4 10%+ Owner 13 Oct 2022, 20:52